The announcement last month of a long-awaited breakthrough in stem-cell research -- the creation of stem-cell lines from a cloned human embryo -- has revived interest in using embryonic stem cells to treat disease. But US regulations mean that many researchers will be watching those efforts from the sidelines.
[More]
0 comments:
Post a Comment